|
|
||||||||
The Annals of Thoracic Surgery, Vol 53, 861-863, Copyright © 1992 by The Society of Thoracic Surgeons
JA Magovern, IY Christlieb, SF Badylak, GC Lantz and RL Kao
Experimental evaluation of new therapy for congestive heart failure has
been hampered by the lack of a simple and reliable animal model of heart
failure. This study was undertaken to develop a canine model of chronic
left ventricular dysfunction. A left thoracotomy was performed in 9 adult
mongrel dogs. A 1.5-mm Silastic (Dow Corning) catheter with an attached
subcutaneous access port was positioned in the left main coronary artery.
Six animals received five weekly infusions of Adriamycin (doxorubicin
hydrochloride) (10 mg/wk), and 3 received saline solution. Hemodynamic
studies were performed before insertion of the catheter and 2 weeks after
completion of the infusions. In animals that received Adriamycin, rest
ejection fraction declined from 0.54 +/- 0.03 to 0.35 +/- 0.03, cardiac
output fell from 5.6 +/- 0.6 to 3.9 +/- 0.5 L/min, and left ventricular
end-diastolic volume increased from 76 +/- 9 to 99 +/- 12 mL (p less than
0.05). There was a small increase in right atrial pressure (2.7 +/- 1
versus 5.7 +/- 1 mm Hg) but no change in right ventricular ejection
fraction (0.31 +/- 0.04 versus 0.30 +/- 0.03). In no animal did alopecia,
weight loss, neutropenia, or anemia develop. Histological changes
consistent with Adriamycin-induced cardiac toxicity were found in each dog.
No significant hemodynamic or histological changes occurred in the control
animals. Administration of Adriamycin into the left main coronary artery
causes left ventricular dysfunction without resulting in systemic side
effects or compromising right ventricular function. This animal model could
be used to evaluate the effects of new possible therapy, such as
cardiomyoplasty, on left ventricular failure.
ARTICLES
A model of left ventricular dysfunction caused by intracoronary adriamycin
Allegheny-Singer Research Institute, Allegheny General Hospital, Pittsburgh, PA 15212.
This article has been cited by other articles:
![]() |
N. Borenstein, V. Chetboul, P. Bruneval, M. Hekmati, R. Tissier, L. Behr, G. Derumeaux, and D. Montarras Non-cultured cell transplantation in an ovine model of non-ischemic heart failure Eur. J. Cardiothorac. Surg., March 1, 2007; 31(3): 444 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Christiansen and R. Autschbach Doxorubicin in experimental and clinical heart failure. Eur. J. Cardiothorac. Surg., October 1, 2006; 30(4): 611 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hasenfuss Animal models of human cardiovascular disease, heart failure and hypertrophy Cardiovasc Res, July 1, 1998; 39(1): 60 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Toyoda, M. Okada, and M. A. Kashem A canine model of dilated cardiomyopathy induced by repetitive intracoronary doxorubicin administration J. Thorac. Cardiovasc. Surg., June 1, 1998; 115(6): 1367 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Waterford, J. R. Van Camp, M. A. Gallagher, M. T. Anderson, S. F. Bolling, and L. A. Brunsting III Adjustable Model of Chronic Left Ventricular Dysfunction Ann. Thorac. Surg., December 1, 1997; 64(6): 1682 - 1685. [Abstract] [Full Text] |
||||
![]() |
M. Vaynblat, M. Chiavarelli, H. R. Shah, G. Ramdev, M. Aron, Z. Zisbrod, and J. N. Cunningham Jr Cardiac Binding in Experimental Heart Failure Ann. Thorac. Surg., July 1, 1997; 64(1): 81 - 85. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |